Advanced search
Publication Cover
Bioengineered Volume 12, 2021 - Issue 1
Submit an article Journal homepage
1,557
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Silencing of the chemokine CXC receptor 4 (CXCR4) hampers cancer progression and increases cisplatin (DDP)-sensitivity in clear cell renal cell carcinoma (ccRCC)

Wenguang Wanga Department of Urology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, ChinaView further author information
,
Zhilu Ganb Department of Urology, The Third People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, ChinaView further author information
,
Qiang Liua Department of Urology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, ChinaView further author information
,
Shenshen Yana Department of Urology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, ChinaView further author information
,
Rexiti Mulatia Department of Urology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, ChinaView further author information
&
Yujie Wanga Department of Urology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4326-720XView further author information
ORCID Icon
Pages 2957-2969 | Received 31 Mar 2021, Accepted 09 Jun 2021, Published online: 28 Jun 2021

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.